Logo image of DXST

DECENT HOLDING INC-A (DXST) Stock Fundamental Analysis

USA - NASDAQ:DXST - KYG2748R1065 - Common Stock

1.3001 USD
-0.17 (-11.56%)
Last: 9/19/2025, 8:00:01 PM
1.3788 USD
+0.08 (+6.05%)
After Hours: 9/19/2025, 8:00:01 PM
Fundamental Rating

5

Overall DXST gets a fundamental rating of 5 out of 10. We evaluated DXST against 84 industry peers in the Commercial Services & Supplies industry. DXST is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DXST is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

DXST had positive earnings in the past year.
DXST had a negative operating cash flow in the past year.
DXST Yearly Net Income VS EBIT VS OCF VS FCFDXST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 500K 1M 1.5M 2M 2.5M

1.2 Ratios

The Return On Assets of DXST (18.72%) is better than 97.62% of its industry peers.
DXST's Return On Equity of 41.92% is amongst the best of the industry. DXST outperforms 96.43% of its industry peers.
DXST has a Return On Invested Capital of 42.35%. This is amongst the best in the industry. DXST outperforms 98.81% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DXST is significantly above the industry average of 10.60%.
The last Return On Invested Capital (42.35%) for DXST is above the 3 year average (40.52%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.72%
ROE 41.92%
ROIC 42.35%
ROA(3y)19.33%
ROA(5y)N/A
ROE(3y)48.14%
ROE(5y)N/A
ROIC(3y)40.52%
ROIC(5y)N/A
DXST Yearly ROA, ROE, ROICDXST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 20 40 60

1.3 Margins

DXST has a Profit Margin of 18.22%. This is amongst the best in the industry. DXST outperforms 95.24% of its industry peers.
Looking at the Operating Margin, with a value of 21.70%, DXST belongs to the top of the industry, outperforming 96.43% of the companies in the same industry.
DXST has a Gross Margin (27.83%) which is in line with its industry peers.
Industry RankSector Rank
OM 21.7%
PM (TTM) 18.22%
GM 27.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DXST Yearly Profit, Operating, Gross MarginsDXST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30 40

More info and screens

7

2. Health

2.1 Basic Checks

DXST has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for DXST remains at a similar level compared to 1 year ago.
The debt/assets ratio for DXST has been reduced compared to a year ago.
DXST Yearly Shares OutstandingDXST Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M
DXST Yearly Total Debt VS Total AssetsDXST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 4.67 indicates that DXST is not in any danger for bankruptcy at the moment.
DXST has a Altman-Z score of 4.67. This is in the better half of the industry: DXST outperforms 76.19% of its industry peers.
DXST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.67
ROIC/WACC5.62
WACC7.53%
DXST Yearly LT Debt VS Equity VS FCFDXST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 1M 2M 3M 4M 5M

2.3 Liquidity

DXST has a Current Ratio of 1.57. This is a normal value and indicates that DXST is financially healthy and should not expect problems in meeting its short term obligations.
DXST has a Current ratio (1.57) which is comparable to the rest of the industry.
DXST has a Quick Ratio of 1.57. This is a normal value and indicates that DXST is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.57, DXST is in the better half of the industry, outperforming 63.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.57
DXST Yearly Current Assets VS Current LiabilitesDXST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

DXST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.11%, which is quite good.
DXST shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.18%.
EPS 1Y (TTM)13.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5533.33%
Revenue 1Y (TTM)22.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%341.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DXST Yearly Revenue VS EstimatesDXST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

DXST is valuated reasonably with a Price/Earnings ratio of 10.00.
DXST's Price/Earnings ratio is rather cheap when compared to the industry. DXST is cheaper than 90.48% of the companies in the same industry.
When comparing the Price/Earnings ratio of DXST to the average of the S&P500 Index (27.38), we can say DXST is valued rather cheaply.
Industry RankSector Rank
PE 10
Fwd PE N/A
DXST Price Earnings VS Forward Price EarningsDXST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DXST indicates a somewhat cheap valuation: DXST is cheaper than 76.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.99
DXST Per share dataDXST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

The decent profitability rating of DXST may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DXST!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DECENT HOLDING INC-A

NASDAQ:DXST (9/19/2025, 8:00:01 PM)

After market: 1.3788 +0.08 (+6.05%)

1.3001

-0.17 (-11.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.13M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10
Fwd PE N/A
P/S 1.83
P/FCF N/A
P/OCF N/A
P/B 4.21
P/tB 4.22
EV/EBITDA 7.99
EPS(TTM)0.13
EY10%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.71
BVpS0.31
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.72%
ROE 41.92%
ROCE 49.79%
ROIC 42.35%
ROICexc 46.08%
ROICexgc 46.14%
OM 21.7%
PM (TTM) 18.22%
GM 27.83%
FCFM N/A
ROA(3y)19.33%
ROA(5y)N/A
ROE(3y)48.14%
ROE(5y)N/A
ROIC(3y)40.52%
ROIC(5y)N/A
ROICexc(3y)70.44%
ROICexc(5y)N/A
ROICexgc(3y)70.73%
ROICexgc(5y)N/A
ROCE(3y)56.88%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 85.45%
Cap/Sales 0.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.57
Altman-Z 4.67
F-Score2
WACC7.53%
ROIC/WACC5.62
Cap/Depr(3y)511.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5533.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%341.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-136.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-126.32%
OCF growth 3YN/A
OCF growth 5YN/A